ArticleTocilizumab and Remdesivir Versus Remdesivir Alone in Treatment of Hospitalized Patients with Severe COVID-19 Pneumonia
ArticleTocilizumab and Remdesivir Versus Remdesivir Alone in Treatment of Hospitalized Patients with Severe COVID-19 Pneumonia
ArticleClinical outcome of Remdesivir in the treatment of a severe and critically ill elderly patient with COVID-19 infection.
ArticleClinical outcome of Remdesivir in the treatment of a severe and critically ill elderly patient with COVID-19 infection.
ArticleRadiological and inflammatory outcome in severe covid-19 patients received tocilizumab versus high dose of methylprednisolone
ArticleRadiological and inflammatory outcome in severe covid-19 patients received tocilizumab versus high dose of methylprednisolone
ArticleThe Effect of Age on Clinical Presentation in Cases with Moderate to Severe COVID-19 Pneumonia
ArticleThe Effect of Age on Clinical Presentation in Cases with Moderate to Severe COVID-19 Pneumonia
ArticleThe clinical presentations and outcomes in a cohort of hospitalized elderly COVID-19 Egyptian patients: A cross-sectional study
ArticleThe clinical presentations and outcomes in a cohort of hospitalized elderly COVID-19 Egyptian patients: A cross-sectional study
ArticleC-reactive protein as an early marker of severity and outcome in patients with SARS-CoV-2 infection
ArticleC-reactive protein as an early marker of severity and outcome in patients with SARS-CoV-2 infection
ArticleEfficacy Of Tocilizumab On Critical Intensive Care Unit COVID-19 Patients: Retrospective Study Among Egyptian Armed Forces Hospitals.
ArticleEfficacy Of Tocilizumab On Critical Intensive Care Unit COVID-19 Patients: Retrospective Study Among Egyptian Armed Forces Hospitals.